POCI

MKT CAP:$32M

Precision Optics Corporation, Inc.

Market Cap

$32M

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$4.36+$0.11 (+2.59%)

Apr 21, 2026

Company Details

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentati...

CEO

Joseph N. Forkey

IPO Date

Jan 16, 1992

Website

www.poci.com

Key Metrics TTM

Revenue

$24M

+30.7% YoY

Net Income

-$7M

EPS (Diluted)

-$0.93

Free Cash Flow

-$3M

Revenue / Share

$3.16

Gross Margin

9.7%

Operating Margin

-27.6%

Net Margin

-28.3%

FCF Margin

-13.1%

P/S

1.3x

P/E

—

Earnings Reports

Q3 2026

May 14, 2026

PENDING

Q2 2026

Feb 17, 2026

$7M+62.8%EPS -$0.23

Q1 2026

Nov 13, 2025

$7M+59.2%EPS -$0.21

FY 2025

Sep 29, 2025

$19M-0.1%EPS -$0.85

Q4 2025

Sep 29, 2025

$6M+31.1%EPS -$0.19

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 21	$3M	$785.9K	-$438.4K
Q1 22	$2M	$639.0K	-$572.0K
Q2 22	$4M	$1M	-$460.4K
Q3 22	$5M	$2M	-$61.1K
Q4 22	$5M	$1M	-$430.5K
Q4 23	$5M	$2M	-$614.5K
Q1 24	$4M	$1M	-$405.3K
Q2 24	$5M	$1M	-$704.2K
Q3 24	$5M	$2M	-$258.5K
Q4 24	$5M	$1M	-$1M
Q1 25	$4M	$1M	-$1M
Q2 25	$5M	$1M	-$910.0K
Q3 25	$4M	$418.0K	-$2M
Q4 25	$6M	$799.2K	-$1M
Q1 26	$7M	$946.4K	-$2M
Q2 26	$7M	$204.7K	-$2M

Valuation

Quarter	P/S	P/E
Q4 21	2.1x	—
Q1 22	2.3x	—
Q2 22	3.5x	—
Q3 22	2.5x	—
Q4 22	1.9x	—
Q4 23	2.0x	—
Q1 24	2.0x	—
Q2 24	2.0x	—
Q3 24	1.8x	—
Q4 24	2.0x	—
Q1 25	1.9x	—
Q2 25	1.7x	—
Q3 25	1.6x	—
Q4 25	2.0x	—
Q1 26	1.6x	—
Q2 26	1.3x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 21	$122.0K	$89.0K
Q1 22	-$182.3K	-$212.7K
Q2 22	-$532.8K	-$540.5K
Q3 22	-$164.8K	-$209.4K
Q4 22	-$53.4K	-$123.5K
Q4 23	-$607.5K	-$607.6K
Q1 24	-$1M	-$1M
Q2 24	-$119.8K	-$247.1K
Q3 24	-$214.2K	-$325.5K
Q4 24	-$976.0K	-$987.8K
Q1 25	-$318.6K	-$343.0K
Q2 25	-$786.8K	-$818.8K
Q3 25	-$2M	-$2M
Q4 25	-$569.2K	-$615.5K
Q1 26	$78.2K	-$226.5K
Q2 26	-$256.1K	-$352.4K

Capital Expenditures

Quarter	CapEx
Q4 21	$32.9K
Q1 22	$30.4K
Q2 22	$7.7K
Q3 22	$44.6K
Q4 22	$70.1K
Q4 23	$86
Q1 24	$43.5K
Q2 24	$127.3K
Q3 24	$111.3K
Q4 24	$11.8K
Q1 25	$24.3K
Q2 25	$32.0K
Q3 25	$124.7K
Q4 25	$46.2K
Q1 26	$304.7K
Q2 26	$96.3K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 21	+19.5%	+21.7%
Q1 22	-15.3%	+5.5%
Q2 22	+39.9%	+45.3%
Q3 22	+89.2%	+73.6%
Q4 22	+79.3%	+67.9%
Q4 23	+115.0%	+93.9%
Q1 24	+10.9%	+8.5%
Q2 24	+3.7%	+17.3%
Q3 24	+9.4%	+5.3%
Q4 24	-6.1%	+7.7%
Q1 25	-2.9%	+15.2%
Q2 25	-6.2%	-1.7%
Q3 25	-20.2%	+13.1%
Q4 25	+31.1%	+24.1%
Q1 26	+59.2%	+52.0%
Q2 26	+62.8%	+67.6%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 21	$419.7K	15.7%
Q1 22	$160.1K	6.9%
Q2 22	$350.5K	9.0%
Q3 22	$231.1K	5.0%
Q4 22	$173.9K	3.6%
Q4 23	$149.2K	3.0%
Q1 24	$108.7K	2.5%
Q2 24	$382.4K	7.9%
Q3 24	$258.2K	4.9%
Q4 24	$210.4K	4.5%
Q1 25	$149.4K	3.6%
Q2 25	$308.2K	6.8%
Q3 25	$563.0K	13.4%
Q4 25	$439.9K	7.1%
Q1 26	$301.6K	4.5%
Q2 26	$187.1K	2.5%

OpEx Breakdown

Quarter	R&D	SG&A
Q4 21	$180.6K	$1M
Q1 22	$105.2K	$933.6K
Q2 22	$113.2K	$1M
Q3 22	$214.9K	$2M
Q4 22	$233.2K	$2M
Q4 23	$331.9K	$2M
Q1 24	$212.8K	$2M
Q2 24	$221.7K	$2M
Q3 24	$192.8K	$2M
Q4 24	$354.5K	$2M
Q1 25	$400.7K	$2M
Q2 25	$317.7K	$2M
Q3 25	$211.2K	$2M
Q4 25	$228.3K	$2M
Q1 26	$311.8K	$2M
Q2 26	$249.6K	$2M

Revenue Segments

Quarter	Engineering Design Services	Medical Device	Optical Components	Medical Device Products And Assemblies
Q3 22	$2M	$1M	$2M	—
Q3 24	$2M	—	$2M	$565.3K
Q1 25	$2M	—	$2M	$265.5K
Q2 25	$1M	—	$3M	$337.8K

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 22	$831.6K	$0	$831.6K
Q4 22	$605.7K	$0	$605.7K
Q1 23	$673.5K	$0	$673.5K
Q2 23	$381.3K	$0	$381.3K
Q3 23	$612.1K	$0	$612.1K
Q4 23	$3M	$0	$3M
Q1 24	$1M	$0	$1M
Q2 24	$987.0K	$0	$987.0K
Q3 24	$925.1K	$0	$925.1K
Q4 24	$405.3K	$0	$405.3K
Q1 25	$635.6K	$0	$635.6K
Q2 25	$212.4K	$0	$212.4K
Q3 25	$3M	$0	$3M
Q4 25	$2M	$0	$2M
Q1 26	$1M	$0	$1M
Q2 26	$881.5K	$0	$881.5K

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 21	13M	+183.2%	-2.9%
Q1 22	4M	-66.7%	-2.9%
Q2 22	6M	+24.8%	+25.7%
Q3 22	6M	+1.3%	+19.4%
Q4 22	2M	-66.4%	-85.9%
Q4 23	6M	+202.6%	+28.5%
Q1 24	6M	+6.7%	+9.8%
Q2 24	6M	+0.0%	+8.3%
Q3 24	6M	+0.0%	+222.9%
Q4 24	6M	-0.0%	+6.7%
Q1 25	6M	+2.4%	+2.5%
Q2 25	6M	+2.2%	+4.7%
Q3 25	7M	+8.9%	+14.0%
Q4 25	7M	-1.8%	+11.9%
Q1 26	8M	+13.6%	+24.1%
Q2 26	8M	+0.0%	+21.5%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 21	—	—
Q1 22	—	—
Q2 22	—	—
Q3 22	—	—
Q4 22	—	—
Q4 23	$59.1K	85
Q1 24	$50.8K	85
Q2 24	$56.8K	85
Q3 24	$61.7K	85
Q4 24	$56.1K	84
Q1 25	$50.0K	84
Q2 25	$53.9K	84
Q3 25	$49.8K	84
Q4 25	$68.7K	90
Q1 26	$74.2K	90
Q2 26	$81.9K	90

Revenue / Employee